Targeted Medical Pharma, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$4.5M

232 transactions

Summary

Targeted Medical Pharma, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.5MSales: $2.4M21 insiders

Date	Insider	Type	Value
2016-03-04	Silver David Samuel(Chief Medical Officer)	A	$29K
2016-03-04	Giffoni Kim(Chief Executive Officer)	A	$27K
2016-03-04	Horne William B(Chief Financial Officer)	A	$17K
2015-06-17	Horne William B(Chief Financial Officer)	A	$16K
2015-09-11	Giffoni Kim(Chief Executive Officer)	A	$14K
2015-05-20	Giffoni Kim(Chief Financial Officer)	A	$14K
2015-12-31	Wenkart Thomas Richard	A	$13K
2015-09-11	Horne William B(Chief Financial Officer)	A	$13K
2015-06-30	Wenkart Thomas Richard	A	$12K
2016-03-04	DEWALD MAURICE J	A	$10K
2016-03-04	Weems Kerry Neil	A	$10K
2016-03-04	Wenkart Thomas Richard	A	$10K
2015-11-24	Joint reporting: Giffoni Kim; Giffoni Olena B.; Giffoni Family Trust Dated September 26 2008	Sell	$171.6
2016-03-04	Horne William B(Chief Financial Officer)	A	$0
2016-03-04	DEWALD MAURICE J	A	$0
2016-03-04	Giffoni Kim(Chief Executive Officer)	A	$0
2016-03-04	Silver David Samuel(Chief Medical Officer)	A	$0
2016-03-04	Weems Kerry Neil	A	$0
2016-03-04	Wenkart Thomas Richard	A	$0
2015-06-17	Horne William B(Chief Financial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Targeted Medical Pharma, Inc. — Contributions, Lobbying & Contracts | Poliscope